Detalhe da pesquisa
1.
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.
NPJ Breast Cancer
; 9(1): 68, 2023 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582853